Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...

The United States is preparing to carry out a bold and surprising plan to fight a deadly threat — flesh-eating maggots. Flesh-Eating Maggots Threaten Livestock and Wildlife These maggots are the ...

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.